Phase III study of serplulimab plus chemotherapy as first-line therapy for advanced squamous non-small cell lung cancer: ASTRUM-004 Asian subgroup C. Zhou, Y. Hu,K. Ying,F. Xu,L. Wu, X. Wang,H. Sun,F. Luo, J. Shi, A. Zang, Y. Pan, Z. Chen,Z. Jia, P. Lu, L. Zhang,Y. Cheng, W. Kang, Q. Wang, J. Li,J. ZhuANNALS OF ONCOLOGY（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
